Related Experiment Video
Updated: Jun 9, 2026

Generation of a RIP1 Knockout U937 Cell Line Using the CRISPR-Cas9 System
Published on: April 11, 2025
Chk1 suppressed cell death
1Institute for Cancer Studies, University of Sheffield, School of Medicine and Biomedical Sciences, Sheffield S10 2RX, UK. m.meuth@sheffield.ac.uk.
Abstract:
The role of Chk1 in the cellular response to DNA replication stress is well established. However recent work indicates a novel role for Chk1 in the suppression of apoptosis following the disruption of DNA replication or DNA damage. This review will consider these findings in the context of known pathways of Chk1 signalling and potential applications of therapies that target Chk1.
Insights
Checkpoint kinase 1 (Chk1) is a key regulator of DNA replication stress. New findings reveal Chk1 also suppresses apoptosis after DNA damage, suggesting new therapeutic strategies targeting Chk1.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Checkpoint kinase 1 (Chk1) is crucial for managing cellular responses to DNA replication stress.
- Emerging research highlights a previously unrecognized function of Chk1 in preventing programmed cell death (apoptosis).
Purpose of the Study:
- To review the novel role of Chk1 in apoptosis suppression following DNA replication disruption or DNA damage.
- To contextualize these findings within established Chk1 signaling pathways.
- To explore potential therapeutic applications targeting Chk1.
Main Methods:
- Literature review of recent studies on Chk1 function.
- Analysis of Chk1 signaling pathways.
- Discussion of therapeutic implications.
Main Results:
- Chk1 plays a significant role in preventing apoptosis induced by DNA replication stress.
- This anti-apoptotic function is linked to Chk1's known signaling pathways.
- Targeting Chk1 may offer new avenues for cancer therapy.
Conclusions:
- Chk1 has a dual role in DNA replication stress response and apoptosis suppression.
- Understanding Chk1's novel functions can inform the development of targeted therapies.
- Further research into Chk1 inhibition is warranted for clinical applications.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
The Extrinsic Apoptotic Pathway
Cellular Injury IlI: Cellular Death
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Abnormal Proliferation

